Dogwood Therapeutics Inc.

NASDAQ: DWTX · Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.85
0.62%
After-hours: Sep 18, 2025, 05:48 PM EDT

Dogwood Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
14.85M 3.32M 7.03M 14.01M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
18.13K n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
28.01K 3.56K 7.29K 863.00
Total Current Assets
16.54M 4.17M 8.37M 15.78M
Property-Plant & Equipment
222.65K n/a n/a n/a
Goodwill & Intangibles
77.52M n/a n/a n/a
Total Long-Term Assets
84.67M n/a n/a n/a
Total Assets
94.31M 4.17M 8.37M 15.78M
Account Payables
1.23M 111.91K 573.16K 353.86K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
49.7K n/a n/a n/a
Other Current Liabilities
687.59K n/a 159.7K 532.68K
Total Current Liabilities
3.18M 358.55K 1.04M 1.28M
Long-Term Debt
15.38M n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
26.85M n/a n/a n/a
Total Liabilities
30.03M 358.55K 1.04M 1.28M
Total Debt
15.59M n/a n/a n/a
Book Value
64.28M 3.81M 7.33M 14.5M
Book Value Per Share
62.54 5.07 16.55 43.52
Common Stock
133.00 77.00 1.83K 833.00
Retained Earnings
-73.82M -61.47M -56.17M -43.93M
Comprehensive Income
-3.86M n/a n/a n/a
Shareholders Equity
64.28M 3.81M 7.33M 14.5M
Total Investments
18.13K n/a n/a n/a